Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549662 | SCV000631617 | likely benign | Ehlers-Danlos syndrome, type 4 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659414 | SCV000781227 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771858 | SCV000904578 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002227179 | SCV002506307 | likely benign | not provided | 2022-02-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537921 | SCV004754361 | likely benign | COL3A1-related disorder | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000549662 | SCV004826841 | likely benign | Ehlers-Danlos syndrome, type 4 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000771858 | SCV005032184 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |